title: Perioperative Management to Reduce Cardiovascular Events.
authors.affiliation: From Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, NY (N.R.S., J.S.B.); Division of Hematology, Department of Medicine, New York University School of Medicine, New York, NY (J.S.B.); and Division of Vascular Surgery, Department of Surgery, New York University School of Medicine, New York, NY (J.S.B.).
authors.forename: Nathaniel R
authors.initials: NR
authors.lastname: Smilowitz
authors.affiliation: From Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, NY (N.R.S., J.S.B.); Division of Hematology, Department of Medicine, New York University School of Medicine, New York, NY (J.S.B.); and Division of Vascular Surgery, Department of Surgery, New York University School of Medicine, New York, NY (J.S.B.). jeffrey.berger@nyumc.org.
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Berger
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000758:Anesthesia / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D019645:Arthroplasty, Replacement, Knee; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D000075202:Contraindications; D003327:Coronary Disease / Q000150:complications / Q000628:therapy; D004198:Disease Susceptibility; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D019990:Perioperative Care / Q000379:methods*; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control*; D019106:Postoperative Hemorrhage / Q000139:chemically induced; D011229:Preanesthetic Medication; D012307:Risk Factors; D040242:Risk Reduction Behavior; D013312:Stress, Physiological; D013514:Surgical Procedures, Operative / Q000009:adverse effects; D019851:Thrombophilia / Q000188:drug therapy / Q000209:etiology; D013988:Ticlopidine / Q000031:analogs & derivatives
chemical_list: D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin